These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30468644)

  • 41. Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein.
    Chen SJ; Jiaang WT
    Curr Top Med Chem; 2011; 11(12):1447-63. PubMed ID: 21510839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation.
    Chung KM; Hsu SC; Chu YR; Lin MY; Jiaang WT; Chen RH; Chen X
    PLoS One; 2014; 9(2):e88772. PubMed ID: 24551161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours.
    Dohi O; Ohtani H; Hatori M; Sato E; Hosaka M; Nagura H; Itoi E; Kokubun S
    Histopathology; 2009 Oct; 55(4):432-40. PubMed ID: 19817894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
    Cao F; Wang S; Wang H; Tang W
    Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata.
    Brokopp CE; Schoenauer R; Richards P; Bauer S; Lohmann C; Emmert MY; Weber B; Winnik S; Aikawa E; Graves K; Genoni M; Vogt P; Lüscher TF; Renner C; Hoerstrup SP; Matter CM
    Eur Heart J; 2011 Nov; 32(21):2713-22. PubMed ID: 21292680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).
    Jansen K; Heirbaut L; Verkerk R; Cheng JD; Joossens J; Cos P; Maes L; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
    J Med Chem; 2014 Apr; 57(7):3053-74. PubMed ID: 24617858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
    Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
    Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice.
    Panaro BL; Coppage AL; Beaudry JL; Varin EM; Kaur K; Lai JH; Wu W; Liu Y; Bachovchin WW; Drucker DJ
    Mol Metab; 2019 Jan; 19():65-74. PubMed ID: 30477988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast activation protein restrains adipogenic differentiation and regulates matrix-mediated mTOR signaling.
    Blomberg R; Beiting DP; Wabitsch M; Puré E
    Matrix Biol; 2019 Oct; 83():60-76. PubMed ID: 31325484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression pattern of dipeptidyl peptidase IV activity and/or structure homologues in cancer.
    Kotacková L; Baláziová E; Sedo A
    Folia Biol (Praha); 2009; 55(3):77-84. PubMed ID: 19545486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
    Gunderson AJ; Yamazaki T; McCarty K; Phillips M; Alice A; Bambina S; Zebertavage L; Friedman D; Cottam B; Newell P; Gough MJ; Crittenden MR; Van der Veken P; Young KH
    PLoS One; 2019; 14(2):e0211117. PubMed ID: 30726287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integral membrane protease fibroblast activation protein sensitizes fibrosarcoma to chemotherapy and alters cell death mechanisms.
    Baird SK; Rigopoulos A; Cao D; Allan L; Renner C; Scott FE; Scott AM
    Apoptosis; 2015 Nov; 20(11):1483-98. PubMed ID: 26342814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers in Tumor Microenvironment? Upregulation of Fibroblast Activation Protein-α Correlates with Gastric Cancer Progression and Poor Prognosis.
    Hu M; Qian C; Hu Z; Fei B; Zhou H
    OMICS; 2017 Jan; 21(1):38-44. PubMed ID: 28206814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
    Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
    Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasensitive Fluorescent Probes Reveal an Adverse Action of Dipeptide Peptidase IV and Fibroblast Activation Protein during Proliferation of Cancer Cells.
    Gong Q; Shi W; Li L; Wu X; Ma H
    Anal Chem; 2016 Aug; 88(16):8309-14. PubMed ID: 27444320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
    Zhang Z; Tao J; Qiu J; Cao Z; Huang H; Xiao J; Zhang T
    Cell Oncol (Dordr); 2024 Apr; 47(2):361-381. PubMed ID: 37726505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the radiolabeled boronic acid-based FAP inhibitor MIP-1232 for atherosclerotic plaque imaging.
    Meletta R; Müller Herde A; Chiotellis A; Isa M; Rancic Z; Borel N; Ametamey SM; Krämer SD; Schibli R
    Molecules; 2015 Jan; 20(2):2081-99. PubMed ID: 25633335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients.
    Bracke A; De Hert E; De Bruyn M; Claesen K; Vliegen G; Vujkovic A; van Petersen L; De Winter FHR; Hotterbeekx A; Brosius I; Theunissen C; Van Ierssel S; van Frankenhuijsen M; Vlieghe E; Vercauteren K; Van der Veken P; Hendriks D; Kumar-Singh S; De Meester I
    Clin Chim Acta; 2022 Jun; 531():4-11. PubMed ID: 35283094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
    Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
    Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.